Position in JNJ
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$5,766,134
+$39,639 QoQ
Shares Held
22,704
-3.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.60%
of 13F equity value
Holder Rank
#1,512
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MERIDIAN INVESTMENT COUNSEL INC. holds $23,634,584 across 8 Drug Manufacturers - General names. JNJ ranks #2 (24.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
25,506 | $6,418,329 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
22,704 | $5,766,134 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
31,450 | $3,973,393 | |
| 4 | NVO |
Novo Nordisk A S
|
63,091 | $3,024,582 | |
| 5 | AMGN |
Amgen Inc
|
6,995 | $2,533,029 | |
| 6 | PFE |
Pfizer Inc
|
50,187 | $1,208,502 | |
| 7 | MRK |
Merck & Co., Inc.
|
3,923 | $504,105 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,584 | $206,510 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,766,134 | 22,704 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $5,726,495 | 23,427 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $4,908,854 | 23,720 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $4,477,707 | 24,149 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $3,688,759 | 24,149 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $3,945,831 | 23,793 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $3,395,099 | 23,476 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $3,667,255 | 22,629 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $2,765,201 | 18,919 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $2,889,498 | 18,266 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,870,379 | 18,313 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $3,147,396 | 20,208 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $4,708,547 | 28,447 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $4,414,555 | 28,481 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $4,972,874 | 28,151 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $4,530,136 | 27,731 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $4,445,915 | 25,046 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $4,453,967 | 25,131 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $4,282,053 | 25,031 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,767,956 | 23,331 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $3,811,424 | 23,136 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $3,779,392 | 22,996 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $3,619,110 | 22,996 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $3,483,792 | 23,400 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $3,306,211 | 23,510 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $3,082,866 | 23,510 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||